Sana Biotechnology Inc.

Last updated September 27, 2026

Favorite this organization

Organization details

Legal name: Sana Biotechnology Inc.
Ownership: Public
Status: Active
Sector (GICS): Health Care
SIC code: 2836 — Biological Products, (No Diagnostic Substances)
Jurisdiction of incorporation: Delaware
Headquarters city: Seattle
Headquarters state / province: Washington
Headquarters country: United States
Fiscal year end: December
Ticker symbol: SANA
Primary stock exchange: Nasdaq

Identifiers

SEC CIK: 0001770121
EIN: 83-1381173
Wikidata ID: Q106301980

Board of directors

Follow this board

Alise Reicin · Director
Since 2023
Douglas G. Cole · Director
Since 2023
Hans Edgar Bishop · Director
Since 2023
Joshua H. Bilenker · Director
Since 2023
Mary Agnes Wilderotter · Director Overboarded
Since 2023
Michelle Seitz · Director
Since 2023
Patrick Y. Yang · Director
Since 2023
Richard Mulligan · Director · Head of SanaX
Since 2023
Robert L. Rosiello · Director
Since 2025
Robert Nelsen · Director Overboarded
Since 2023
Steve Harr · Director · President & CEO
Since 2023

Chief executives

Steve Harr · President & CEO

Dates unknown

Director election results

Annual meeting of June 4, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Board connections

8 of this board's directors also sit on 22 other boards. 12 are in the same sector.

Shared director Other board Same sector +6 more in the list below

Lyell Immunopharma Inc. Same sector
via Hans Edgar Bishop and Robert Nelsen
Agilent Technologies Inc.
via Hans Edgar Bishop
Bausch Health Companies Inc. Same sector
via Richard Mulligan
City Therapeutics Inc. Same sector
via Robert Nelsen
Costco Wholesale Corporation
via Mary Agnes Wilderotter
Denali Therapeutics Inc. Same sector
via Douglas G. Cole
DocuSign Inc.
via Mary Agnes Wilderotter
Foghorn Therapeutics Inc. Same sector
via Douglas G. Cole
Fortinet Inc.
via Mary Agnes Wilderotter
Honeywell Aerospace Inc.
via Michelle Seitz
Immatics N.V. Same sector
via Alise Reicin
International Flavors & Fragrances Inc.
via Richard Mulligan
Kardigan Inc. Same sector
via Robert Nelsen
Lyft Inc.
via Mary Agnes Wilderotter
MSCI Inc.
via Michelle Seitz
MetLife Inc.
via Michelle Seitz
Okta Inc.
via Mary Agnes Wilderotter
Prime Medicine Inc. Same sector
via Robert Nelsen
Q32 Bio Inc. Same sector
via Alise Reicin
Seres Therapeutics Inc. Same sector
via Robert L. Rosiello
Tectonic Therapeutic Inc. Same sector
via Alise Reicin
Vir Biotechnology Inc. Same sector
via Robert Nelsen

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months: $0; 0 purchases by 0 insiders
Sold, last 12 months: $0; 0 sales by 0 insiders

Date	Insider	Transaction	Shares	Price	Value
Oct 5, 2026	Hans Edgar Bishop Director	Grant or award	+8,680	—	—
Aug 27, 2026	PATEL DHAVALKUMAR DHIRAJLAL Officer (EVP, Chief Scientific Officer)	Shares withheld for tax	−41,158	$4.11	$169,159
Aug 26, 2026	PATEL DHAVALKUMAR DHIRAJLAL Officer (EVP, Chief Scientific Officer)	Option exercise	+125,000	—	—
Jul 6, 2026	Hans Edgar Bishop Director	Grant or award	+6,297	—	—
Apr 6, 2026	Hans Edgar Bishop Director	Grant or award	+7,763	—	—
Mar 9, 2026	Steve Harr Director, Officer (President & CEO)	Shares withheld for tax	−11,526	$3.13	$36,076
Mar 9, 2026	Wyrick Susan D. Officer (See Remarks)	Shares withheld for tax	−3,342	$3.13	$10,460
Mar 9, 2026	Steve Harr Director, Officer (President & CEO)	Shares withheld for tax	−12,819	$3.10	$39,739
Mar 9, 2026	Wyrick Susan D. Officer (See Remarks)	Shares withheld for tax	−1,045	$3.10	$3,240
Mar 7, 2026	Steve Harr Director, Officer (President & CEO)	Option exercise	+50,000	—	—
Mar 7, 2026	Wyrick Susan D. Officer (See Remarks)	Option exercise	+3,250	—	—
Mar 6, 2026	Steve Harr Director, Officer (President & CEO)	Option exercise	+41,666	—	—
Mar 6, 2026	Wyrick Susan D. Officer (See Remarks)	Option exercise	+10,416	—	—
Mar 3, 2026	Wyrick Susan D. Officer (See Remarks)	Shares withheld for tax	−491	$3.91	$1,920
Mar 2, 2026	Wyrick Susan D. Officer (See Remarks)	Option exercise	+1,525	—	—

Peers

Compare boards

Organizations in the same sector, closest in location and size first.

3M Company NYSE: MMM · ST Paul, United States Organization ABVC BioPharma Inc. Nasdaq: ABVC · Fremont, United States Organization ACADIA Pharmaceuticals Inc. Nasdaq: ACAD · SAN Diego, United States Organization ADMA Biologics Inc Nasdaq: ADMA · Ramsey, United States Organization

Questions about Sana Biotechnology Inc.

Who is the CEO of Sana Biotechnology Inc.?

Steve Harr is Sana Biotechnology Inc.'s President & CEO.

How many directors are on Sana Biotechnology Inc.'s board?

Sana Biotechnology Inc.'s board has 11 directors: Alise Reicin, Douglas G. Cole, Hans Edgar Bishop, Joshua H. Bilenker, Mary Agnes Wilderotter, Michelle Seitz, Patrick Y. Yang, Richard Mulligan, Robert L. Rosiello, Robert Nelsen and 1 other.

How is Sana Biotechnology Inc. connected to…? → Spot something wrong? Report a correction

Embed this board on your site

Paste this where the board should appear. It always shows the current directors and links back here.

<div data-bod-board="sana-biotechnology-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>

Reviews (0)

No reviews yet. Be the first to write one.